-
CancerDrug DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in Science
-
Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.
CancerCell and Gene TherapyChildren's HealthNovartis Institutes for BioMedical ResearchOncology -
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.
Biomedical ResearchData ScienceDrug DevelopmentDrug DiscoveryEmerging Technology -
Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.
Biomedical ResearchCOVID-19Drug DiscoveryNovartis Institutes for BioMedical ResearchScientific Research -
From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.
CancerInnovationScientific ResearchOncology -
Novartis researchers aim to improve the lives of patients with osteoarthritis.
Drug DiscoveryMusculoskeletal DiseasesScientific ResearchDrug Development -
We’re working to bring the hope of advanced medicine to more patients.
CancerDrug DiscoveryInnovationOncologyScientific Research -
Targeting inflammation to fight cancer is a new approach with a long history.
CancerDiseasesScientific Research -
A conversation with Novartis Chief Digital Officer Bertrand Bodson
InnovationNovartis Institutes for BioMedical ResearchWorking at Novartis -
Molecular glues are a new type of medicine inspired by nature’s matchmakers.
Drug DesignInnovationNovartis Institutes for BioMedical ResearchScientific Research -
Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.
Neurodegenerative DiseaseNeuroscienceNovartis Institutes for BioMedical ResearchScientific ResearchAlzheimer’s disease -
Novartis researchers are working to extend the life of organ transplants
InnovationMedical InnovationsNovartis Institutes for BioMedical ResearchClinical ResearchClinical Trials